These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6325044)
21. Effects of ritanserin, a specific serotonin-S2 receptor antagonist, on the release of anterior pituitary hormones during insulin-induced hypoglycemia in normal humans. Tepavcević D; Giljević Z; Aganović I; Korsić M; Halimi S; Suchanek E; Jelić T; Kozić B; Plavsić V J Endocrinol Invest; 1995 Jun; 18(6):427-30. PubMed ID: 7594236 [TBL] [Abstract][Full Text] [Related]
22. Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release. Copinschi G; L'Hermite M; Leclercq R; Golstein J; Vanhaelst L; Virasoro E; Robyn C J Clin Endocrinol Metab; 1975 Mar; 40(3):442-9. PubMed ID: 163844 [TBL] [Abstract][Full Text] [Related]
23. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. Pitchot W; Wauthy J; Legros JJ; Ansseau M Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031 [TBL] [Abstract][Full Text] [Related]
24. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects. Papalia D; Lunetta M; Di Mauro M J Endocrinol Invest; 1989 Dec; 12(11):777-82. PubMed ID: 2693516 [TBL] [Abstract][Full Text] [Related]
25. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans. Matzen S; Secher NH; Knigge U; Pawelczyk J; Perko G; Iversen H; Bach FW; Warberg J Acta Physiol Scand; 1993 Oct; 149(2):163-76. PubMed ID: 8266806 [TBL] [Abstract][Full Text] [Related]
26. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects. Schüle C; Baghai T; Laakmann G Neuroendocrinology; 2004 Jan; 79(1):54-62. PubMed ID: 14755134 [TBL] [Abstract][Full Text] [Related]
27. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man. Arvat E; Maccagno B; Ramunni J; Gianotti L; Di Vito L; Deghenghi R; Camanni F; Ghigo E J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817 [TBL] [Abstract][Full Text] [Related]
28. Ketanserin does not prevent ACTH-induced hypertension in sheep. Nelson MA; Coghlan JP; Denton DA; Whitworth JA; Scoggins BA Clin Exp Pharmacol Physiol; 1985; 12(2):155-9. PubMed ID: 2988838 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles. Hickey G; Jacks T; Judith F; Taylor J; Schoen WR; Krupa D; Cunningham P; Clark J; Smith RG Endocrinology; 1994 Feb; 134(2):695-701. PubMed ID: 8299565 [TBL] [Abstract][Full Text] [Related]
30. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Schüle C; Baghai T; Schmidbauer S; Bidlingmaier M; Strasburger CJ; Laakmann G Psychoneuroendocrinology; 2004 Feb; 29(2):185-200. PubMed ID: 14604600 [TBL] [Abstract][Full Text] [Related]
31. Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia. Wakabayashi I; Demura R; Miki N; Ohmura E; Miyoshi H; Shizume K J Clin Endocrinol Metab; 1980 Mar; 50(3):597-9. PubMed ID: 6987258 [TBL] [Abstract][Full Text] [Related]
32. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs. Rushen J; Schwarze N; Ladewig J; Foxcroft G Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062 [TBL] [Abstract][Full Text] [Related]
33. ACTH in normal children and children with pituitary and adrenal diseases. II. Plasma ACTH (cortisol and growth hormone) values during insulin hypoglycaemia--patients with idiopathic hypopituitarism and intracranial tumour. Petersen KE Acta Paediatr Scand; 1984 May; 73(3):372-8. PubMed ID: 6331059 [TBL] [Abstract][Full Text] [Related]
34. Hypokalaemia during insulin-induced hypoglycaemia in hypopituitary adults with and without growth hormone deficiency. Davies JS; Hinds NP; Millward EM; McDowell I; Scanlon MF Clin Endocrinol (Oxf); 1998 Aug; 49(2):217-20. PubMed ID: 9828910 [TBL] [Abstract][Full Text] [Related]
35. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia. Goji K Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990 [TBL] [Abstract][Full Text] [Related]
36. The role of serotonin (5-HT) in the control of TSH and prolactin release in euthyroid subjects as assessed by the administration of ketanserin (5-HT2 antagonist) and zimelidine (5-HT re-uptake inhibitor). O'Malley BP; Jennings PE; Cook N; Barnett DB; Rosenthal FD Psychoneuroendocrinology; 1984; 9(1):13-9. PubMed ID: 6234610 [TBL] [Abstract][Full Text] [Related]
37. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. Jacks T; Hickey G; Judith F; Taylor J; Chen H; Krupa D; Feeney W; Schoen W; Ok D; Fisher M J Endocrinol; 1994 Nov; 143(2):399-406. PubMed ID: 7830002 [TBL] [Abstract][Full Text] [Related]
38. Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome. Prescott RW; Ratcliffe WA; Taylor PK Br Med J (Clin Res Ed); 1984 Sep; 289(6448):787-8. PubMed ID: 6089950 [TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Bearn J; Allain T; Coskeran P; Munro N; Butler J; McGregor A; Wessely S Biol Psychiatry; 1995 Feb; 37(4):245-52. PubMed ID: 7711161 [TBL] [Abstract][Full Text] [Related]